(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-bromophenyl)propanoic acid, 98%, 250mg

7-Methoxy-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 1g

4-(3-Methoxy-4-nitrophenyl)morpholine, 25g

2,5-Dibromopyrazine, 96.0%, 5g

(2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95.0%, 250mg

Methyl 2-chloroquinazoline-8-carboxylate, 95.0%, 500mg

1-(6-Methoxypyridin-3-yl)cyclopropanamine, 95%, 250mg

Chloro(3-chloropropyl)dimethylsilane>96.0%(GC)1mL

(E)-2-(benzo[d]thiazol-2-yl)-3-(4-(dimethylamino)phenyl)acrylonitrile, 98%, 1g

2,4-Dibromoquinazoline, 95.0%, 1g

tert-Butyl 1-amino-3,6,9,12-tetraoxapentadecan-15-oate, 95.0%, 10g

3-(3,4-Difluorophenyl)propanamide, 95%, 250mg

3,3,5-Trimethylcyclohexyl Acrylate (cis- and trans- mixture) (stabilized with MEHQ)>98.0%(GC)25g